Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found b...

Descripción completa

Detalles Bibliográficos
Autores principales: Camprubí, Daniel, Almuedo-Riera, Alex, Martí-Soler, Helena, Soriano, Alex, Hurtado, Juan Carlos, Subirà, Carme, Grau-Pujol, Berta, Krolewiecki, Alejandro, Muñoz, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657540/
https://www.ncbi.nlm.nih.gov/pubmed/33175880
http://dx.doi.org/10.1371/journal.pone.0242184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657540/
https://www.ncbi.nlm.nih.gov/pubmed/33175880
http://dx.doi.org/10.1371/journal.pone.0242184

Ejemplares similares